Delivery Order SPE2DE24D0013-SPE2D625F1LDS
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a $4,815 delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 7, 2025, with ultimate completion targeted for August 21, 2025. This firm fixed-price delivery order carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The award is likely associated with one of Cepheid's existing Indefinite Delivery Vehicle contracts with...
- The U.S. Defense Department's Medical Supply Chain agency awarded a delivery order valued at $1,361.79 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, issued on August 20, 2025, with an ultimate completion date of August 27, 2025, represents work to be performed at Cepheid's Sunnyvale facility. The contract carries no set-aside designation and is identified as delivery order XPRSMVP-10 under contract number...
- The U.S. Defense Department's Medical Supply Chain organization awarded Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, a $4,108.25 firm fixed-price delivery order (Contract No. 4569031063) on August 7, 2025, with completion scheduled for August 14, 2025. This delivery order carries no set-aside designation and represents a procurement of diagnostic solutions from Cepheid's established product portfolio. The award leverages Cepheid's expertise in molecular...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $13,600 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. Issued on August 14, 2025, with an ultimate completion date of August 21, 2025, this delivery order (XPRS4PLEX-10) carries no set-aside designation and represents a short-term procurement under one of Cepheid's existing indefinite delivery vehicle contracts. The place of performance is Sunnyvale,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $2,471.70 by the Defense Department's Medical Supply Chain organization on July 18, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order carries no set-aside designation and represents procurement of diagnostic equipment, reagents, or testing services from Cepheid's core product portfolio, which includes GeneXpert...
- The U.S. Defense Department's Medical Supply Chain organization awarded a delivery order valued at $1,190.28 to Cepheid Inc. on August 14, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order does not utilize any set-aside designation and represents a discrete procurement under a broader federal vehicle. Cepheid, a molecular diagnostics manufacturer based in Sunnyvale, California, specializes in providing advanced diagnostic systems and test kits for...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $1,840 on August 11, 2025, by the Defense Department's Medical Supply Chain agency. This firm fixed-price contract, designated as XPRSTREPA-10, is set to conclude by August 18, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract represents a discrete delivery order under Cepheid's existing federal contracting relationships, through which the...
- The U.S. Defense Department's Medical Supply Chain agency awarded a delivery order valued at $2,040 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, under contract XPRS4PLEX-10. This firm fixed-price delivery order, issued on August 11, 2025, with an ultimate completion date of August 18, 2025, represents a continuation of Cepheid's ongoing provision of diagnostic solutions to federal healthcare systems. The contract carries no set-aside designation,...
- Cepheid, a leading manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a delivery order valued at $2,471.70 by the Medical Supply Chain division of the Defense Department on August 7, 2025. This firm fixed-price delivery order, which carries no set-aside designation, is scheduled for ultimate completion by August 21, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract award references XPRSARS-COV2-10, indicating the delivery order...
- The U.S. Defense Department's Medical Supply Chain has awarded a $5,082 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, for SARS-CoV-2 testing supplies. The contract, awarded on August 4, 2025, with an ultimate completion date of August 18, 2025, carries no set-aside designation and will be performed at Cepheid's primary facility in Sunnyvale. This delivery order falls under Cepheid's existing indefinite delivery vehicle...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F1LDSDelivery Order
The U.S. Defense Medical Supply Chain awarded a $1,854 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 20, 2025, with an ultimate completion date of August 27, 2025. This delivery order carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The award is associated with Cepheid's broader federal contracting portfolio, which includes two significant Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs Veterans Integrated Service Networks valued at approximately $35.3 million through 2030, providing molecular diagnostic testing systems, reagents, and assays for infectious disease detection and clinical laboratory microbiology. Cepheid specializes in advanced diagnostic systems and test kits, with a core product line centered on GeneXpert diagnostic platforms and associated molecular reagents designed to detect conditions including COVID-19, influenza, respiratory syncytial virus, methicillin-resistant Staphylococcus aureus, and other infectious diseases. The company has established itself as a key supplier of molecular diagnostic solutions across multiple federal healthcare systems, including the Veterans Health Administration, Defense Health Agency, Defense Logistics Agency, and Indian Health Service. This delivery order represents a continuation of Cepheid's role as a primary provider of diagnostic technologies and testing services to the federal defense and veterans healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/20/25 |